Stock listing
NASDAQ:AGEN Agenus Inc. Stock
Home listing (NASDAQ) of Agenus Inc.
Follow Agenus Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:AGEN
$6.51 USD +0.11 (+1.7%)
Close on Oct 22, 2026
- Day range
- $6.24 – $6.52 USDOct 22, 2026
- Volume
- 553,901 sharesOct 22, 2026
- Market cap
- $294.0M USDAt the close on Oct 22, 2026 · price × 45.16M shares outstanding
- 52-week range
- $2.71 – $10.31 USDLowest and highest trades, Oct 23, 2025 – Oct 22, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AGEN · Home | $6.51 USD | +0.11 (+1.7%) | 553,901 | $6.32 | $6.52 | $6.236 | $6.40 | Close on Oct 22, 2026 |
| Frankfurt:AJ8 | €5.55 EUR | -0.05 (-0.9%) | 3,372 | €5.55 | €5.55 | €5.55 | €5.60 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 22, 2026 – Oct 22, 2026 · NASDAQ:AGEN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.51 | +0.11 | +1.7% | $6.32 | $6.52 | $6.236 | 553,901 | |
| $6.40 | -0.02 | -0.3% | $6.459 | $6.54 | $6.31 | 789,524 | |
| $6.42 | +0.24 | +3.9% | $6.10 | $6.58 | $6.05 | 819,337 | |
| $6.18 | +0.14 | +2.3% | $6.13 | $6.30 | $6.055 | 734,858 | |
| $6.04 | -0.64 | -9.6% | $6.65 | $6.70 | $6.00 | 1,028,732 | |
| $6.68 | +0.18 | +2.8% | $6.52 | $6.99 | $6.51 | 815,431 | |
| $6.50 | -0.45 | -6.5% | $6.88 | $7.14 | $6.46 | 980,140 | |
| $6.95 | -0.48 | -6.5% | $7.30 | $7.34 | $6.81 | 991,800 | |
| $7.43 | -0.24 | -3.1% | $7.63 | $7.66 | $7.39 | 572,500 | |
| $7.67 | +0.13 | +1.7% | $7.50 | $7.79 | $7.38 | 710,200 | |
| $7.54 | -0.03 | -0.4% | $7.57 | $7.66 | $7.24 | 1,214,800 | |
| $7.57 | +0.08 | +1.1% | $7.28 | $7.62 | $7.27 | 1,155,100 | |
| $7.49 | -1.24 | -14.2% | $8.49 | $8.49 | $7.47 | 1,522,900 | |
| $8.73 | +0.37 | +4.4% | $8.54 | $8.76 | $8.11 | 956,100 | |
| $8.36 | +0.03 | +0.4% | $8.36 | $8.61 | $8.08 | 1,085,200 | |
| $8.33 | -1.60 | -16.1% | $9.95 | $9.99 | $8.28 | 1,949,200 | |
| $9.93 | +0.04 | +0.4% | $9.92 | $10.31 | $9.62 | 1,366,600 | |
| $9.89 | +0.46 | +4.9% | $9.66 | $10.06 | $9.43 | 1,500,000 | |
| $9.43 | +0.89 | +10.4% | $8.71 | $9.71 | $8.47 | 2,764,000 | |
| $8.54 | +0.04 | +0.5% | $8.57 | $8.68 | $8.40 | 672,400 | |
| $8.50 | +0.10 | +1.2% | $8.32 | $8.60 | $8.20 | 635,700 | |
| $8.40 | -0.30 | -3.4% | $8.70 | $8.70 | $8.39 | 610,000 | |
| $8.70 | +0.37 | +4.4% | $8.26 | $8.82 | $8.16 | 993,300 | |
| $8.33 | +0.48 | +6.1% | $7.80 | $8.60 | $7.60 | 1,299,400 | |
| $7.85 | +0.63 | +8.7% | $7.48 | $7.88 | $7.33 | 2,084,000 | |
| $7.22 | +0.01 | +0.1% | $7.31 | $7.40 | $7.09 | 765,400 | |
| $7.21 | +0.05 | +0.7% | $7.25 | $7.33 | $7.06 | 686,000 | |
| $7.16 | +0.03 | +0.4% | $7.05 | $7.19 | $6.81 | 779,500 | |
| $7.13 | +0.19 | +2.7% | $7.03 | $7.18 | $6.82 | 752,200 | |
| $6.94 | +0.05 | +0.7% | $6.93 | $7.02 | $6.70 | 790,500 | |
| $6.89 | +0.03 | +0.4% | $6.76 | $7.04 | $6.66 | 893,600 | |
| $6.86 | -0.57 | -7.7% | $7.60 | $7.61 | $6.78 | 1,445,700 | |
| $7.43 | -0.81 | -9.8% | $8.14 | $8.18 | $7.42 | 1,207,300 | |
| $8.24 | 0.00 | 0.0% | $8.14 | $8.38 | $7.99 | 986,200 | |
| $8.24 | +0.15 | +1.9% | $8.12 | $8.31 | $7.98 | 738,700 | |
| $8.09 | +0.10 | +1.3% | $8.07 | $8.28 | $7.69 | 663,700 | |
| $7.99 | +0.38 | +5.0% | $7.56 | $8.00 | $7.54 | 676,300 | |
| $7.61 | -0.05 | -0.7% | $7.68 | $7.76 | $7.50 | 719,300 | |
| $7.66 | -0.15 | -1.9% | $7.98 | $8.07 | $7.61 | 741,100 | |
| $7.81 | -0.44 | -5.3% | $8.28 | $8.52 | $7.78 | 782,800 | |
| $8.25 | -0.11 | -1.3% | $8.30 | $8.40 | $8.03 | 776,700 | |
| $8.36 | +0.69 | +9.0% | $7.80 | $8.50 | $7.80 | 1,181,200 | |
| $7.67 | -0.42 | -5.2% | $8.07 | $8.07 | $7.60 | 772,900 | |
| $8.09 | +0.60 | +8.0% | $7.58 | $8.35 | $7.58 | 1,517,300 | |
| $7.49 | -0.77 | -9.3% | $8.22 | $8.25 | $7.31 | 1,575,700 | |
| $8.26 | +0.73 | +9.7% | $7.66 | $8.73 | $7.62 | 2,290,400 | |
| $7.53 | +0.38 | +5.3% | $7.13 | $7.65 | $7.08 | 967,600 | |
| $7.15 | -0.17 | -2.3% | $7.30 | $7.31 | $6.96 | 831,300 | |
| $7.32 | +0.32 | +4.6% | $6.93 | $7.46 | $6.83 | 1,251,900 | |
| $7.00 | +0.10 | +1.4% | $6.85 | $7.03 | $6.71 | 624,900 | |
| $6.90 | +0.07 | +1.0% | $6.91 | $7.20 | $6.83 | 1,154,200 | |
| $6.83 | -0.17 | -2.4% | $6.84 | $6.90 | $6.42 | 1,373,600 | |
| $7.00 | +0.04 | +0.6% | $6.83 | $7.09 | $6.36 | 1,923,000 | |
| $6.96 | -0.53 | -7.1% | $7.52 | $7.55 | $6.92 | 1,191,000 | |
| $7.49 | -0.29 | -3.7% | $7.67 | $8.85 | $7.32 | 2,455,500 | |
| $7.78 | -0.52 | -6.3% | $8.35 | $8.52 | $7.69 | 1,457,500 | |
| $8.30 | +0.48 | +6.1% | $7.85 | $8.38 | $7.75 | 2,017,300 | |
| $7.82 | +0.32 | +4.3% | $7.65 | $8.09 | $7.50 | 1,654,300 | |
| $7.50 | -0.41 | -5.2% | $7.79 | $7.98 | $7.32 | 1,573,800 | |
| $7.91 | +1.28 | +19.3% | $6.77 | $7.99 | $6.51 | 2,999,200 | |
| $6.63 | +0.03 | +0.5% | $6.61 | $6.95 | $6.48 | 1,857,200 | |
| $6.60 | +0.47 | +7.7% | $6.06 | $6.64 | $5.88 | 2,783,300 | |
| $6.13 | +0.15 | +2.5% | $5.99 | $6.20 | $5.87 | 1,234,000 | |
| $5.98 | -0.21 | -3.4% | $6.20 | $6.23 | $5.81 | 1,248,900 | |
| $6.19 | +0.66 | +11.9% | $5.53 | $6.23 | $5.46 | 2,333,400 | |
| $5.53 | -0.05 | -0.9% | $5.57 | $5.89 | $5.50 | 1,698,700 |
- Ticker
- NASDAQ:AGEN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Agenus to Provide Third Quarter 2026 Financial Report and Development Update
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 33 slides
Calls
Replays
Agenus (NASDAQ:AGEN) Q2 2025 Earnings Call
Wed, Aug 27, 2025 · 9:30 AM ET
Watch TranscriptAgenus (NASDAQ:AGEN) Q4 2024 Earnings Call
Tue, Mar 11, 2025 · 8:30 AM ET
Watch TranscriptAgenus (NASDAQ:AGEN) Q3 2024 Earnings Call
Tue, Nov 12, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Agenus to Participate in Chardan’s 10th Annual Healthcare Investor Conference
Oct 9, 2026
Closed $7.67 (+1.7%) on Oct 9, 2026
Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
Oct 8, 2026
Closed $7.54 (-0.4%) on Oct 8, 2026
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Oct 3, 2026
Closed $8.73 (+4.4%) on Oct 5, 2026
Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
Oct 2, 2026
Closed $8.36 (+0.4%) on Oct 2, 2026
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Sep 10, 2026
Closed $6.89 (+0.4%) on Sep 10, 2026
Agenus to Participate in Upcoming September Investor Conferences
Aug 31, 2026
Closed $7.61 (-0.7%) on Aug 31, 2026
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism
Aug 28, 2026
Closed $7.66 (-1.9%) on Aug 28, 2026
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer
Aug 26, 2026
Closed $8.25 (-1.3%) on Aug 26, 2026
Agenus: Q2 Earnings Snapshot
Aug 7, 2026
Closed $7.00 (+0.6%) on Aug 10, 2026
Financings
Private placement of common stock or pre-funded warrants with Series A and Series B purchase warrants
Jul 13, 2026
Announced: US$85M–US$340M · an accompanying Series A purchase warrant and Series B purchase warrant that, if fully…
Buyers: Commodore Capital; RA Capital Management; TCGX; Invus; Ligand Pharmaceuticals
Use of proceeds: Advance BOT+BAL in neoadjuvant MSS colon cancer, including the registrational Phase 3 ROBBIN trial
Decks
Investor Presentation (October 2026)
Investor deck · 33 slides · October 2026
Corporate Update (July 2026)
Corporate update · 31 slides · Jul 13, 2026
Agenus Corporate Event at ESMO 2023
Conference · 34 slides · Oct 22, 2023
Investor Day (November 2022)
Investor day · 131 slides · Nov 12, 2022
Agenus Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 180 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest Aug 27, 2025
- Decks
- 25 decks · latest October 2026
Where Agenus Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AGEN · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A403RK | LS Exchange | Germany | EUR |
| Lang & Schwarz:A403RK | Lang & Schwarz | Germany | EUR |
| gettex:AJ8 | gettex | Germany | EUR |
| BX Swiss:AGEN | BX Swiss | Switzerland | CHF |
| BOATS:AGEN | BOATS | United States | USD |
| Dusseldorf:AJ8 | Dusseldorf | Germany | EUR |
| Frankfurt:AJ8 | Frankfurt | Germany | EUR |
| Munich:AJ8 | Munich | Germany | EUR |
| Tradegate:AJ8 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Agenus Inc.